等待開盤 09-20 09:30:00 美东时间
+0.110
+2.09%
Nkarta Inc : Mizuho Cuts Target Price to $20 From $25
08-16 20:48
Nkarta (NASDAQ:NKTX) shares spiked in the premarket Wednesday after Raymond James upgraded the cell therapy developer to Strong Buy from Outperform, citing a compelling valuation setup following the c...
08-14 20:24
Nkarta, Inc. : H.c. Wainwright Cuts Target Price to $22 From $23
08-14 18:13
Nkarta (NASDAQ:NKTX) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.47) by 27.66 percent. This is a 50 percent increase over losses of $(0.68) per share from the same
08-14 04:13
Nkarta Inc - Expects Its Current Cash and Cash Equivalents Will Be Sufficient t...
08-14 04:01
Nkarta Announces Initiation of Investigator-Sponsored Clinical Trial Evaluating...
07-24 18:00
Nkarta, Inc. (NASDAQ:NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced changes to its leadership team. Nadir Mahmood, Ph.D., will join Nkarta as President this
07-16 18:03
Nkarta Announces Leadership Updates, Appoints Nadir Mahmood as President
07-16 18:01
Emily Bodnar, an analyst from H.C. Wainwright, has initiated a new Buy rating o...
06-28 00:05